Trypanosoma cruzi: Activity of heterocyclic cationic molecules in vitro

Michele Gabriele de Oliveira Pacheco, Cristiane França da Silva, Elen Mello de Souza, Marcos Meuser Batista, Patrícia Bernardino da Silva, Arvind Kumar, Chad E. Stephens, David W. Boykin, Maria de Nazaré C. Soeiro

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Chagas disease remains a serious public health problem in several Latin American countries. New chemotherapy is urgently needed since current drugs are limited in efficacy and exhibit undesirable side effects. Aromatic diamidines and analogs are well known anti-parasitic agents and in this study, we have evaluated the in vitro trypanocidal effect of several different heterocyclic cationic compounds, including diamidines (DB1195, DB1196 and DB1345), a monoamidine (DB824), an arylimidamide (DB613A) and a guanylhydrazone (DB1080) against amastigotes and bloodstream trypomastigotes of Trypanosoma cruzi, the etiological agent of Chagas disease. Our present findings showed that all compounds exerted, at low-micromolar doses, a trypanocidal effect upon both intracellular parasites and bloodstream trypomastigotes of T. cruzi. The activity of DB1195, DB1345, DB824 and DB1080 against bloodstream forms was reduced when these compounds were assayed in the presence of mouse blood possibly due to their association with plasma constituents and/or due to metabolic instability of the compounds. However, trypanocidal effects of DB613A and DB1196 were not affected by plasma constituents, suggesting their potential application in the prophylaxis of banked blood. In addition, potency and selectivity of DB613A, towards intracellular parasites, corroborate previous results that demonstrated the highly promising activity of arylimidamides against this parasite, which justify further studies in experimental models of T. cruzi infection.

Original languageEnglish (US)
Pages (from-to)73-80
Number of pages8
JournalExperimental Parasitology
Volume123
Issue number1
DOIs
StatePublished - Sep 1 2009

Fingerprint

Trypanosoma cruzi
Pentamidine
Parasites
Chagas Disease
Heterocyclic Compounds
Theoretical Models
Public Health
Drug Therapy
Infection
Pharmaceutical Preparations
In Vitro Techniques

Keywords

  • Chagas disease
  • Diamidines
  • Trypanosoma cruzi

ASJC Scopus subject areas

  • Parasitology
  • Immunology
  • Infectious Diseases

Cite this

Pacheco, M. G. D. O., Silva, C. F. D., Souza, E. M. D., Batista, M. M., Silva, P. B. D., Kumar, A., ... Soeiro, M. D. N. C. (2009). Trypanosoma cruzi: Activity of heterocyclic cationic molecules in vitro. Experimental Parasitology, 123(1), 73-80. https://doi.org/10.1016/j.exppara.2009.06.004

Trypanosoma cruzi : Activity of heterocyclic cationic molecules in vitro. / Pacheco, Michele Gabriele de Oliveira; Silva, Cristiane França da; Souza, Elen Mello de; Batista, Marcos Meuser; Silva, Patrícia Bernardino da; Kumar, Arvind; Stephens, Chad E.; Boykin, David W.; Soeiro, Maria de Nazaré C.

In: Experimental Parasitology, Vol. 123, No. 1, 01.09.2009, p. 73-80.

Research output: Contribution to journalArticle

Pacheco, MGDO, Silva, CFD, Souza, EMD, Batista, MM, Silva, PBD, Kumar, A, Stephens, CE, Boykin, DW & Soeiro, MDNC 2009, 'Trypanosoma cruzi: Activity of heterocyclic cationic molecules in vitro', Experimental Parasitology, vol. 123, no. 1, pp. 73-80. https://doi.org/10.1016/j.exppara.2009.06.004
Pacheco MGDO, Silva CFD, Souza EMD, Batista MM, Silva PBD, Kumar A et al. Trypanosoma cruzi: Activity of heterocyclic cationic molecules in vitro. Experimental Parasitology. 2009 Sep 1;123(1):73-80. https://doi.org/10.1016/j.exppara.2009.06.004
Pacheco, Michele Gabriele de Oliveira ; Silva, Cristiane França da ; Souza, Elen Mello de ; Batista, Marcos Meuser ; Silva, Patrícia Bernardino da ; Kumar, Arvind ; Stephens, Chad E. ; Boykin, David W. ; Soeiro, Maria de Nazaré C. / Trypanosoma cruzi : Activity of heterocyclic cationic molecules in vitro. In: Experimental Parasitology. 2009 ; Vol. 123, No. 1. pp. 73-80.
@article{b74a65a27e0040519acd351b5a26b23d,
title = "Trypanosoma cruzi: Activity of heterocyclic cationic molecules in vitro",
abstract = "Chagas disease remains a serious public health problem in several Latin American countries. New chemotherapy is urgently needed since current drugs are limited in efficacy and exhibit undesirable side effects. Aromatic diamidines and analogs are well known anti-parasitic agents and in this study, we have evaluated the in vitro trypanocidal effect of several different heterocyclic cationic compounds, including diamidines (DB1195, DB1196 and DB1345), a monoamidine (DB824), an arylimidamide (DB613A) and a guanylhydrazone (DB1080) against amastigotes and bloodstream trypomastigotes of Trypanosoma cruzi, the etiological agent of Chagas disease. Our present findings showed that all compounds exerted, at low-micromolar doses, a trypanocidal effect upon both intracellular parasites and bloodstream trypomastigotes of T. cruzi. The activity of DB1195, DB1345, DB824 and DB1080 against bloodstream forms was reduced when these compounds were assayed in the presence of mouse blood possibly due to their association with plasma constituents and/or due to metabolic instability of the compounds. However, trypanocidal effects of DB613A and DB1196 were not affected by plasma constituents, suggesting their potential application in the prophylaxis of banked blood. In addition, potency and selectivity of DB613A, towards intracellular parasites, corroborate previous results that demonstrated the highly promising activity of arylimidamides against this parasite, which justify further studies in experimental models of T. cruzi infection.",
keywords = "Chagas disease, Diamidines, Trypanosoma cruzi",
author = "Pacheco, {Michele Gabriele de Oliveira} and Silva, {Cristiane Fran{\cc}a da} and Souza, {Elen Mello de} and Batista, {Marcos Meuser} and Silva, {Patr{\'i}cia Bernardino da} and Arvind Kumar and Stephens, {Chad E.} and Boykin, {David W.} and Soeiro, {Maria de Nazar{\'e} C.}",
year = "2009",
month = "9",
day = "1",
doi = "10.1016/j.exppara.2009.06.004",
language = "English (US)",
volume = "123",
pages = "73--80",
journal = "Experimental Parasitology",
issn = "0014-4894",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Trypanosoma cruzi

T2 - Activity of heterocyclic cationic molecules in vitro

AU - Pacheco, Michele Gabriele de Oliveira

AU - Silva, Cristiane França da

AU - Souza, Elen Mello de

AU - Batista, Marcos Meuser

AU - Silva, Patrícia Bernardino da

AU - Kumar, Arvind

AU - Stephens, Chad E.

AU - Boykin, David W.

AU - Soeiro, Maria de Nazaré C.

PY - 2009/9/1

Y1 - 2009/9/1

N2 - Chagas disease remains a serious public health problem in several Latin American countries. New chemotherapy is urgently needed since current drugs are limited in efficacy and exhibit undesirable side effects. Aromatic diamidines and analogs are well known anti-parasitic agents and in this study, we have evaluated the in vitro trypanocidal effect of several different heterocyclic cationic compounds, including diamidines (DB1195, DB1196 and DB1345), a monoamidine (DB824), an arylimidamide (DB613A) and a guanylhydrazone (DB1080) against amastigotes and bloodstream trypomastigotes of Trypanosoma cruzi, the etiological agent of Chagas disease. Our present findings showed that all compounds exerted, at low-micromolar doses, a trypanocidal effect upon both intracellular parasites and bloodstream trypomastigotes of T. cruzi. The activity of DB1195, DB1345, DB824 and DB1080 against bloodstream forms was reduced when these compounds were assayed in the presence of mouse blood possibly due to their association with plasma constituents and/or due to metabolic instability of the compounds. However, trypanocidal effects of DB613A and DB1196 were not affected by plasma constituents, suggesting their potential application in the prophylaxis of banked blood. In addition, potency and selectivity of DB613A, towards intracellular parasites, corroborate previous results that demonstrated the highly promising activity of arylimidamides against this parasite, which justify further studies in experimental models of T. cruzi infection.

AB - Chagas disease remains a serious public health problem in several Latin American countries. New chemotherapy is urgently needed since current drugs are limited in efficacy and exhibit undesirable side effects. Aromatic diamidines and analogs are well known anti-parasitic agents and in this study, we have evaluated the in vitro trypanocidal effect of several different heterocyclic cationic compounds, including diamidines (DB1195, DB1196 and DB1345), a monoamidine (DB824), an arylimidamide (DB613A) and a guanylhydrazone (DB1080) against amastigotes and bloodstream trypomastigotes of Trypanosoma cruzi, the etiological agent of Chagas disease. Our present findings showed that all compounds exerted, at low-micromolar doses, a trypanocidal effect upon both intracellular parasites and bloodstream trypomastigotes of T. cruzi. The activity of DB1195, DB1345, DB824 and DB1080 against bloodstream forms was reduced when these compounds were assayed in the presence of mouse blood possibly due to their association with plasma constituents and/or due to metabolic instability of the compounds. However, trypanocidal effects of DB613A and DB1196 were not affected by plasma constituents, suggesting their potential application in the prophylaxis of banked blood. In addition, potency and selectivity of DB613A, towards intracellular parasites, corroborate previous results that demonstrated the highly promising activity of arylimidamides against this parasite, which justify further studies in experimental models of T. cruzi infection.

KW - Chagas disease

KW - Diamidines

KW - Trypanosoma cruzi

UR - http://www.scopus.com/inward/record.url?scp=68049148349&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68049148349&partnerID=8YFLogxK

U2 - 10.1016/j.exppara.2009.06.004

DO - 10.1016/j.exppara.2009.06.004

M3 - Article

C2 - 19520077

AN - SCOPUS:68049148349

VL - 123

SP - 73

EP - 80

JO - Experimental Parasitology

JF - Experimental Parasitology

SN - 0014-4894

IS - 1

ER -